Frontline Ltd. (FRO): Don’t disregard this ominous signal – Invest Chronicle
Home  »  Finance   »  Frontline Ltd. (FRO): Don’t disregard this o...

Frontline Ltd. (FRO): Don’t disregard this ominous signal

Frontline Ltd. (FRO) is priced at $7.57 after the most recent trading session. At the very opening of the session, the stock price was $8.06 and reached a high price of $8.235, prior to closing the session it reached the value of $7.86. The stock touched a low price of $7.85.Recently in News on May 2, 2022, Freeline To Present at the 25th Annual Meeting of the American Society of Gene and Cell Therapy. Five abstracts accepted with new research and technology insights and data to further enhance AAV-based gene therapy candidates. You can read further details here

Frontline Ltd. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $10.43 on 03/07/22, with the lowest value was $6.10 for the same time period, recorded on 01/24/22.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Frontline Ltd. (FRO) full year performance was 0.13%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Frontline Ltd. shares are logging -27.43% during the 52-week period from high price, and 24.02% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $6.10 and $10.43.

The company’s shares, operating in the sector of Energy managed to top a trading volume set approximately around 1391839 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Frontline Ltd. (FRO) recorded performance in the market was 11.17%, having the revenues showcasing 9.02% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.63B, as it employees total of 79 workers.

Frontline Ltd. (FRO) in the eye of market guru’s

During the last month, 0 analysts gave the Frontline Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 8.08, with a change in the price was noted +0.91. In a similar fashion, Frontline Ltd. posted a movement of +13.68% for the period of last 100 days, recording 2,433,063 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for FRO is recording 1.43 at the time of this writing. In addition, long term Debt to Equity ratio is set at 1.31.

Frontline Ltd. (FRO): Stocks Technical analysis and Trends

Raw Stochastic average of Frontline Ltd. in the period of last 50 days is set at 3.59%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 5.02%. In the last 20 days, the company’s Stochastic %K was 12.89% and its Stochastic %D was recorded 15.27%.

If we look into the earlier routines of Frontline Ltd., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 11.17%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -7.09%, alongside a boost of 0.13% for the period of the last 12 months. The shares increased approximately by -10.58% in the 7-day charts and went up by -16.20% in the period of the last 30 days. Common stock shares were driven by 9.02% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts